PDC30聊天机器人 - - 关于痴呆症精神教育资源的开发家庭护理人员之间的痴呆症护理:混合方法可接受性研究
Sheung-Tak Cheng1, Peter H F Ng2,3
1Department of Health and Physical Education, The Education University of Hong Kong, Tai Po, China (Hong Kong).
JMIR aging
|January 6, 2025
概括
一个新的AI聊天机器人,PDC30,提供有用,可访问的痴呆症护理支持. 护理人员发现它很用户友好,并会向其他人推这种对话式AI.
科学领域:
- 医疗保健中的人工智能
- 痴呆症护理研究研究
- 人与计算机的交互
背景情况:
- 对于痴呆症护理人员支持的日益增长的需求构成了医疗保健方面的重大挑战.
- 交谈式人工智能 (AI) 为持续的护理人员协助提供了一个潜在的24/7解决方案.
研究的目的:
- 开发一个生成的人工智能聊天机器人,PDC30聊天机器人,用于痴呆症护理人员的支持.
- 评估PDC30聊天机器人在家庭护理人员中使用混合方法方法的可接受性.
主要方法:
- PDC30聊天机器人是使用GPT-4o和一个人格代理构建的,该代理人经过了积极痴呆症护理30天指南手册的培训.
- 聊天机器人响应与ChatGPT和Chatbot-B (使用权威来源) 相比较.
- 21名家庭护理人员参加了为期2周的试验,以评估PDC30聊天机器人的可接受性.
主要成果:
- PDC30聊天机器人和聊天机器人-B提供了情境敏感的建议,表现优于ChatGPT.
- 护理人员将PDC30聊天机器人评为用户友好,有帮助,易于理解.
- 从护理人员反中获得的关键主题包括帮助力,可访问性和对人工智能的更积极态度.
结论:
- PDC30聊天机器人为痴呆症护理人员的询问提供高质量,受欢迎的响应.
- 交谈式人工智能为增强护理人员支持系统提供了一种实用和有效的方法.
关键词:
这就是阿尔茨海默病的原因.提供护理 提供护理聊天机器人 聊天机器人交谈式的人工智能痴呆症 痴呆症是一种痴呆症.数字健康数字健康医疗保健技术 技术 医疗保健技术语言模型语言模型医学创新 医学创新手机电话 手机电话手机电话心理教育的精神教育.更多相关视频
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
3.7K
08:25Collecting Saliva and Measuring Salivary Cortisol and Alpha-amylase in Frail Community Residing Older Adults via Family Caregivers
Published on: December 18, 2013
11.4K
相关概念视频
01:24Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
1.5K
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
1.5K
01:24Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation
1.2K
Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about...
1.2K
01:30Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94
01:20Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
1.7K
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
1.7K
01:26Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
01:22Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161